Tuberculosis in HIV-infected patients: a comprehensive review
Open accessAbstract
The incidence of tuberculosis (TB) is currently increasing in HIV-infected patients living in Africa and Asia, where TB endemicity is high, reflecting the susceptibility of this group of patients to mycobacteria belonging to the TB group. In this population, extension of multiple resistance to anti-tuberculous drugs is also a matter of anxiety. HIV-induced immunosuppression modifies the clinical presentation of TB, resulting in atypical signs and symptoms, and more frequent extrapulmonary dissemination. The treatment of TB is also more difficult to manage in HIV-infected patients, particularly with regard to pharmacological interactions secondary to inhibition or induction of cytochrome P450 enzymes by protease inhibitors with rifampicin or rifabutin, respectively. Finally, immune restoration induced by highly active anti-retroviral therapy (HAART) in developed countries may be responsible for a paradoxical worsening of TB manifestations.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Extrapulmonary tuberculosis, including lymphatic tuberculosis, is more common among immunocompromised patients, including those with HIV infection.
“Extrapulmonary tuberculosis, including lymphatic tuberculosis, is more common among immunocompromised patients, including those with HIV infection [20, 21].”
From Current diagnosis and management of peripheral tuberculous lymphadenitis. (2011) · cites this paper as [20]
M tuberculosis lineage strains are associated with the site of tuberculosis disease; strains mostly distributed through Southeast Asia and the Indian Subcontinent (such as M tuberculosis Beijing/W strain) are more likely to cause extrapulmonary disease.
“A few studies have shown that M tuberculosis lineage strains are associated with the site of tuberculosis disease. The strains mostly distributed through Southeast Asia and the Indian Subcontinent (such as M tuberculosis Beijing/W strain) are more likely to cause extrapulmonary disease.9–11”
From Epidemiology and Diagnosis of Tuberculous Lymphadenitis in a Tuberculosis Low-Burden Country (2015) · cites this paper as [9]
Cites
Dye, C., Scheele, S., >Dolin, P., Pathania, V. S., Raviglione, M. C., & for the WHO Global Surveillance and Monitoring Project (1999) · JAMA · doi:10.1001/jama.282.7.677 · Cited by 2,955 · see citing works
Tuberculosis in Patients with Human Immunodeficiency Virus Infection
Havlir, D. V., & Barnes, P. F. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902043400507 · Cited by 1,458 · see citing works
Daley, C. L., Small, P. M., Schecter, G. F., Schoolnik, G. K., McAdam, R. A., Jacobs, W. R., & Hopewell, P. C. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260404 · Cited by 986 · see citing works
Ordered accumulation of mutations in HIV protease confers resistance to ritonavir
Molla, A., Korneyeva, M., Gao, Q. C., et al. (1996) · Nature Medicine · doi:10.1038/nm0796-760 · Cited by 770 · see citing works
Immune Reconstitution Inflammatory Syndrome
Shelburne, S. A., Hamill, R. J., Rodriguez‐Barradas, M. C., Greenberg, S. B., Atmar, R. L., Musher, D. M., Gathe, J., Visnegarwala, F., & Trautner, B. W. (2002) · Medicine · doi:10.1097/00005792-200205000-00005 · Cited by 654 · see citing works
Paradoxical Worsening of Tuberculosis Following Antiretroviral Therapy in Patients with AIDS
NARITA, M., ASHKIN, D., HOLLENDER, E. S., & PITCHENIK, A. E. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.1.9712001 · Cited by 608 · see citing works
Jones, B. E., Young, S. M. M., Antoniskis, D., Davidson, P. T., Kramer, F., & Barnes, P. F. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/148.5.1292 · Cited by 586 · see citing works
The mortality and pathology of HIV infection in a West African city
Lucas, S. B., Hounnou, A., Peacock, C. S., Beaumel, A., Djomand, G., NʼGbichi, J.-M., Yeboué, K. M., Hondé, M., Diomandé, M. I. J. M., Giordano, C., et al. (1993) · AIDS · doi:10.1097/00002030-199312000-00005 · Cited by 561 · see citing works
Badri, M., Wilson, D., & Wood, R. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08904-3 · Cited by 552 · see citing works
Accelerated Course of Human Immunodeficiency Virus Infection after Tuberculosis
Whalen, C., Horsburgh, C. R., Hom, D., Lahart, C., Simberkoff, M. S., & Ellner, J. J. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.1.7812542 · Cited by 532 · see citing works
Sonnenberg, P., Murray, J., Glynn, J. R., Shearer, S., Kambashi, B. S., & Godfrey‐Faussett, P. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06712-5 · Cited by 435 · see citing works
Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy
Jacobson, M. Z., Zegans, M. E., PAVAN, P. R., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(96)11431-8 · Cited by 373 · see citing works
Race, E., Adelson-Mitty, J., Kriegel, G., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(97)04352-3 · Cited by 361 · see citing works
Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy
Dean, G. L., Edwards, S., Ives, N. J., et al. (2002) · AIDS · doi:10.1097/00002030-200201040-00010 · Cited by 354 · see citing works
Ottenhoff, T. H. M., Kumararatne, D. S., & Casanova, J. (1998) · Immunology Today · doi:10.1016/s0167-5699(98)01321-8 · Cited by 326 · see citing works
Vernon, A. N., Burman, W. J., Benator, D., Khan, A., & Bozeman, L. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11467-8 · Cited by 307 · see citing works
Perlman, D. C., El‐Sadr, W. M., Nelson, E. T., Matts, J. P., Telzak, E. E., Salomon, N., Chirgwin, K., & Hafner, R. (1997) · Clinical Infectious Diseases · doi:10.1086/514546 · Cited by 295 · see citing works
Snider, D. E., Raviglione, M. C., & Kochi, A. (2014) · Tuberculosis · doi:10.1128/9781555818357.ch1 · Cited by 288 · see citing works
Halsey, N. A., Coberly, J. S., Desormeaux, J., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(97)06532-x · Cited by 272 · see citing works
Gordin, F. M. (2000) · JAMA · doi:10.1001/jama.283.11.1445 · Cited by 262 · see citing works
Perriëns, J. H., Me, S. L., Mukadi, Y. B., Brown, C., Prignot, J., Pouthier, F., Portaels, F., Jc, W., Mandala, J. K., Kaboto, M., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503233321204 · Cited by 246 · see citing works
Prophylaxis against Opportunistic Infections in Patients with Human Immunodeficiency Virus Infection
Kovacs, J. A., & Masur, H. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005113421907 · Cited by 232 · see citing works
López-Cortés, L. F., Ruiz-Valderas, R., Viciana, P., Alarc??n-Gonz??lez, A., G??mez-Mateos, J., Jiménez, E. M. L., Sarasa-Nacenta, M., L??pez-Pua, Y., & Pach??n, J. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241090-00004 · Cited by 227 · see citing works
Changes in the Transmission of Tuberculosis in New York City from 1990 to 1999
Geng, E. H., Kreiswirth, B. N., Driver, C. R., Li, J., Burzynski, J. N., Della‐Latta, P., LaPaz, A., & Schluger, N. W. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012972 · Cited by 216 · see citing works
Immune Recovery Vitritis Associated With Inactive Cytomegalovirus Retinitis
KARAVELLAS, M. P., Lowder, C. Y., Macdonald, J. C., et al. (1998) · Archives of Ophthalmology · doi:10.1001/archopht.116.2.169 · Cited by 214 · see citing works
HIV-1/AIDS and the control of other infectious diseases in Africa
Corbett, E. L., Steketee, R. W., ter Kuile, F. O., Latif, A. S., Kamali, A., & Hayes, R. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09095-5 · Cited by 210 · see citing works
Pitchenik, A. E., Burr, J., Suarez, M., Fertel, D., Gonzalez, G. E., & MOAS, C. M. (1987) · American Review of Respiratory Disease · doi:10.1164/arrd.1987.135.4.875 · Cited by 169 · see citing works
Tuberculous meningitis in patients with and without human immunodeficiency virus infection
Dubé, M. P., Holtom, P. D., & Larsen, R. A. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90579-z · Cited by 169 · see citing works
Nunn, P. P., Brindle, R., Carpenter, L., Odhiambo, J. A., Wasunna, K. M., Newnham, R. S., Githui, W., Gathua, S., Omwega, M. J., & McAdam, K. P. W. J. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/146.4.849 · Cited by 168 · see citing works
Santoro‐Lopes, G., de Pinho, A. M. F., Harrison, L. H., & Schechter, M. (2002) · Clinical Infectious Diseases · doi:10.1086/338641 · Cited by 167 · see citing works
Tuberculosis and HIV: current status in Africa.
Raviglione, M. C., Harries, A. D., Msiska, R., Wilkinson, D., & Nunn, P. (1997) · PubMed · Cited by 162 · see citing works
Autopsy Study of HIV-1–Positive and H IV-1–Negative Adult Medical Patients in Nairobi, Kenya
Rana, F., Hawken, M. P., Mwachari, C., Bhatt, S. M., Abdullah, F., Nganga, L., Power, C., Githui, W. A., Porter, J. D. H., & Lucas, S. B. (2000) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200005010-00004 · Cited by 162 · see citing works
Perriëns, J. H., Colebunders, R., Karahunga, C., Willame, J.-C., Jeugmans, J., Kaboto, M., Mukadi, Y. B., Pauwels, P., Ryder, R. W., Prignot, J. J., et al. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.4.750 · Cited by 161 · see citing works
Low Antituberculosis Drug Concentrations in Patients with AIDS
Peloquin, C. A., Nitta, A. T., Burman, W. J., et al. (1996) · Annals of Pharmacotherapy · doi:10.1177/106002809603000901 · Cited by 159 · see citing works
Fitzgerald, D. W., Desvarieux, M., Sévère, P., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02870-1 · Cited by 153 · see citing works
Wood, R., Maartens, G., & Lombard, C. J. (2000) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200001010-00010 · Cited by 143 · see citing works
High Incidence of Herpes Zoster in Patients with AIDS Soon After Therapy with Protease Inhibitors
Martínez, E., Gatell, J. M., Moran, Y., et al. (1998) · Clinical Infectious Diseases · doi:10.1086/515019 · Cited by 143 · see citing works
Highly Active Antiretroviral Therapy
Sendi, P., Palmer, A. J., Gafni, A., & Battegay, M. (2001) · PharmacoEconomics · doi:10.2165/00019053-200119070-00001 · Cited by 142 · see citing works
Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients
Foudraine, N. A., Hovenkamp, E., Notermans, D. W., et al. (1999) · AIDS · doi:10.1097/00002030-199902040-00005 · Cited by 139 · see citing works
Increased recurrence of tuberculosis in HIV-1-infected patients in Kenya
Hawken, M. P., Nunn, P., Godfrey‐Faussett, P., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)91474-z · Cited by 132 · see citing works
Pulmonary tuberculosis: comparison of CT findings in HIV-seropositive and HIV-seronegative patients.
Leung, A. N. C., Brauner, M., Gamsu, G., Mlika-Cabanne, N., Romdhane, H. B., Carette, M. F., & Greniér, P. (1996) · Radiology · doi:10.1148/radiology.198.3.8628855 · Cited by 123 · see citing works
Chaisson, R. E., Clermont, H. C., Holt, E., et al. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.4.8887603 · Cited by 122 · see citing works
Drug Malabsorption and Resistant Tuberculosis in HIV-Infected Patients
Patel, K. B., Belmonte, R., & Crowe, H. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320518 · Cited by 122 · see citing works
El-Sadr, W. M., Perlman, D. C., Matts, J. P., Nelson, E. T., Cohn, D. L., Salomon, N., Olibrice, M., Medard, F., Chirgwin, K. D., Mildvan, D., et al. (1998) · Clinical Infectious Diseases · doi:10.1086/520275 · Cited by 119 · see citing works
Crump, J. A., Tyrer, M., Lloyd‐Owen, S. J., et al. (1998) · Clinical Infectious Diseases · doi:10.1086/517636 · Cited by 117 · see citing works
Sidibé, K., Sassan‐Morokro, M., Ackah, A., et al. (1995) · AIDS · doi:10.1097/00002030-199510000-00011 · Cited by 111 · see citing works
Risk Factors for Rifampin Mono-resistant Tuberculosis
Ridzon, R., Whitney, C. G., McKenna, M. T., et al. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.6.9712009 · Cited by 97 · see citing works
Effectiveness of supervised, intermittent therapy for tuberculosis in HIV-infected patients
Alwood, K., Keruly, J. C., Moore-Rice, K., Stanton, D. L., Chaulk, C. P., & Chaisson, R. E. (1994) · AIDS · doi:10.1097/00002030-199408000-00010 · Cited by 93 · see citing works
Garrait, V., Cadranel, J. L., Esvant, H., et al. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.6.2824 · Cited by 84 · see citing works
The treatment of tuberculosis in HIV-infected persons
Pozniak, A. L., Miller, R. F., & Ormerod, P. L. (1999) · AIDS · doi:10.1097/00002030-199903110-00001 · Cited by 80 · see citing works
Bissuel, F., Leport, C., Perronne, C., et al. (1994) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1994.tb00840.x · Cited by 78 · see citing works
Risk Factors for Rifampin-monoresistant Tuberculosis: A Case-Control Study
Sandman, L. A., Schluger, N. W., Davidow, A. L., et al. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.2.9805097 · Cited by 76 · see citing works
Shafer, R. W., Goldberg, R. F., Sierra, M., et al. (1989) · American Review of Respiratory Disease · doi:10.1164/ajrccm/140.6.1611 · Cited by 75 · see citing works
Bradley, S. P., Reed, S. L., & Catanzaro, A. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.5.8630609 · Cited by 67 · see citing works
Factors Affecting the Yield of Acid-fast Sputum Smears in Patients With HIV and Tuberculosis
Smith, R. L., Yew, K., Berkowitz, K. A., & Aranda, C. P. (1994) · CHEST Journal · doi:10.1378/chest.106.3.684 · Cited by 67 · see citing works
Relapse of Tuberculosis After Treatment in Human Immunodeficiency Virus—Infected Patients
Pulido, F. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440230105014 · Cited by 65 · see citing works
Connolly, C., Reid, A., Davies, G., et al. (1999) · AIDS · doi:10.1097/00002030-199908200-00015 · Cited by 64 · see citing works
Tam, C. M., Chan, S. L., Chak Wah, L. A. M., et al. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.6.9707037 · Cited by 64 · see citing works
Perneger, T. V., Sudre, P., Lundgren, J. D., et al. (1995) · BMJ · doi:10.1136/bmj.311.7018.1468 · Cited by 61 · see citing works
Bouza, E. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410040062009 · Cited by 61 · see citing works
Rifampin‐Monoresistant Tuberculosis in New York City, 1993–1994
Munsiff, S. S., Joseph, S., Ebrahimzadeh, A., et al. (1997) · Clinical Infectious Diseases · doi:10.1086/516146 · Cited by 60 · see citing works
Wood, R., Maartens, G., & Lombard, C. J. (2000) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200001010-00010 · Cited by 57 · see citing works
Evolution of Rifampin Resistance in Human Immunodeficiency Virus-Associated Tuberculosis
Nolan, C. M., Williams, D. L., Cave, M. D., Eisenach, K. D., El-Hajj, H. H., Hooton, T. M., Thompson, R. L., & GOLDBERG, S. V. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.3.7663785 · Cited by 56 · see citing works
Salzman, S. H., Schindel, M. L., Aranda, C. P., Smith, R. L., & Lewis, M. L. (1992) · CHEST Journal · doi:10.1378/chest.102.1.143 · Cited by 56 · see citing works
Pulmonary tuberculosis in HIV-infected patients in Zaire
Jh, P. (1996) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(96)85104-3 · Cited by 51 · see citing works
Effect of Isoniazid Chemoprophylaxis on HIV-Related Mycobacterial Disease
Graham, N. M. H. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440080089010 · Cited by 51 · see citing works
Jones, B. E., OTAYA, M., Antoniskis, D., et al. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.6.7952606 · Cited by 50 · see citing works
Kunimoto, D. Y., Chui, L., Nobert, E., et al. (1999) · PubMed · Cited by 44 · see citing works
Moreno, S., Podzamczer, D., Blázquez, R., Iribarren, J. A., Ferrer, E., Repáraz, J., Peña, J. M., Cabrero, E., & Usán, L. (2001) · AIDS · doi:10.1097/00002030-200106150-00018 · Cited by 44 · see citing works
Leonard, M. K., Jr., Larsen, N., Drechsler, H., Blumberg, H. M., Lennox, J. L., Arrellano, M., Filip, J., & Horsburgh, C. R. (2002) · Clinical Infectious Diseases · doi:10.1086/339448 · Cited by 41 · see citing works
Preventive therapy against tuberculosis in people living with HIV.
(1999) · PubMed · Cited by 41 · see citing works
Borin, M. T., Chambers, J. H., Carel, B. J., et al. (1997) · Antiviral Research · doi:10.1016/s0166-3542(97)00011-9 · Cited by 40 · see citing works
Gourevitch, M. N., Hartel, D. M., Selwyn, P. A., et al. (1999) · AIDS · doi:10.1097/00002030-199910220-00009 · Cited by 35 · see citing works
Changes in the Transmission of Tuberculosis in New York
Hammer, A. W. (2002) · New England Journal of Medicine · doi:10.1056/nejm200210313471817 · Cited by 32 · see citing works
Jansà, J. M., Serrano, J., Caylà, J. A., et al. (1998) · PubMed · Cited by 25 · see citing works
New Tuberculosis Drug Development: How Can We Do Better?
O'Brien, R. J., & Vernon, A. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.6.1576 · Cited by 21 · see citing works
[Tuberculosis in patients infected with the human immunodeficiency virus. 30 cases].
Perronne, C., Zahraoui, M., Leport, C., et al. (1988) · PubMed · Cited by 21 · see citing works
Community study of the relative impact of HIV-1 and HIV-2 on intrathoracic tuberculosis
Seng, R., Gustafson, P., Gomes, V. F., et al. (2002) · AIDS · doi:10.1097/00002030-200205030-00013 · Cited by 19 · see citing works
Tuberculosis in Patients Infected with the Human Immunodeficiency Virus
ONG, E., & Mandal, B. K. (1991) · QJM · doi:10.1093/oxfordjournals.qjmed.a068612 · Cited by 15 · see citing works
Ramos, M. D. C., Mc, V., Jacques De Moraes, M., et al. (2000) · PubMed · Cited by 15 · see citing works
Pangon, B., Michon, C., Bizet, C., et al. (1988) · PubMed · Cited by 9 · see citing works
[Pathophysiology and immunology of tuberculosis].
Marchal, G. (1997) · PubMed · Cited by 8 · see citing works
Self-citationTuberculosis in patients infected with the human immunodeficiency virus.
Gérard, M. (1998) · PubMed · Cited by 5 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Holt, S. C., & Ebersole, J. L. (2005) · Periodontology 2000 · doi:10.1111/j.1600-0757.2005.00113.x · Cited by 932 · see citing works
Current diagnosis and management of peripheral tuberculous lymphadenitis.
Fontanilla, J.-M., Barnes, A., & von Reyn, C. F. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir454 · Cited by 299 · see citing works
The Effect of Tuberculosis on Mortality in HIV Positive People: A Meta-Analysis
Straetemans, M., Bierrenbach, A. L., Nagelkerke, N., Glaziou, P., & van der Werf, M. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015241 · Cited by 68 · see citing works
Epidemiology and Diagnosis of Tuberculous Lymphadenitis in a Tuberculosis Low-Burden Country
Salvador, F., Los-Arcos, I., Sánchez-Montalvá, A., Tórtola, T., Curran, A., Villar, A., Saborit, N., Castellví, J., & Molina, I. (2015) · Medicine · doi:10.1097/md.0000000000000509 · Cited by 43 · see citing works
“infection; in these patients, the disease is almost always secondary to reactivation of a latent tuberculosis infection.(12) The present study shows a prevalence of HIV infection among patients with TL of 15.”
BackgroundMa, J., Vongpradith, A., Ledesma, J. R., Novotney, A., Yi, S., Lim, K., Hay, S. I., Murray, C. J. L., & Kyu, H. H. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07891-5 · Cited by 9 · see citing works
- Authors
- Aaron, L., Saadoun, D., Calatroni, I., Launay, O., Mémain, N., Vincent, V., Marchal, G., Dupont, B., Bouchaud, O., Valeyre, D., & Lortholary, O.
- Affiliations
- Hôpital Necker-Enfants Malades (FR)
- Hôpital Avicenne (FR)
- Institut Pasteur (FR)
- Corresponding author
- Lortholary, O.
- Venue
- Clinical Microbiology and Infection
- Publisher
- Elsevier BV
- Published
- 2004-05
- Volume
- 10
- Issue
- 5
- Pages
- 388-398
- ISSN
- 1198-743X (ISSN-L)
- OpenAlex
- W2095960037
- Cited by
- 330
- References
- 85
- Citations by year
- 2026: 3 · 2025: 13 · 2024: 14 · 2023: 9 · 2022: 16 · 2021: 12 · 2020: 15 · 2019: 11 · 2018: 15 · 2017: 22 · 2016: 15 · 2015: 16 · 2014: 14 · 2013: 14 · 2012: 19
- FWCI
- 2.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Clinical Microbiology and Infection (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Surgery › Infectious Diseases and Tuberculosis
- Health Sciences › Medicine › Surgery › Diagnosis and treatment of tuberculosis
- Keywords
- tuberculosis, HIV infection, drug-resistant tuberculosis, extrapulmonary tuberculosis, atypical presentation, protease inhibitors, rifampicin, rifabutin, cytochrome P450 interactions, immune reconstitution, highly active antiretroviral therapy, Mycobacterium tuberculosis
- MeSH terms
- Antitubercular Agents, Drug Therapy, Combination, Humans, Tuberculosis, HIV Infections, AIDS-Related Opportunistic Infections, Tuberculosis, Multidrug-Resistant, Anti-HIV Agents, Antiretroviral Therapy, Highly Active
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review